Journal Editorial Report: The week's best and worst from Kim Strassel, Jason Riley and Dan Henninger. Remember when the University of California kicked off a trend by eliminating the SAT test as an ...
Funding round was led by Yosemite, with participation from new investors Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, and all existing investors SAN ...
A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...
Funding round was led by Yosemite, with participation from new investors Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, and all existing investors Solve ...
In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer agents-antibody-drug conjugates (ADCs)-can dramatically improve ...
Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of its new IR820 and IR870 infrared dye antibody conjugates. For the ...
We are moving from a world of institutional dependency to one of personal responsibility. The question is no longer, “What can we do for people?” but, “How can we equip people to do more for ...
Abstract: For the conjugate gradient method to solve the unconstrained optimization problem, given a new interval method to obtain the direction parameters, and a new conjugate gradient algorithm is ...
Sven, a sales leader, received a call from a major customer who was furious. Their order arrived late, the product was damaged, and to top it off, their invoice didn’t reflect the volume discount ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback